GlaxoSmithKline (GSK) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
GlaxoSmithKline (GSK) has announced that its issued share capital as of October 31, 2024, consists of over 4.3 billion ordinary shares, with a total of approximately 4.1 billion voting rights available. This information is crucial for shareholders calculating their interest in the company as per regulatory guidelines.
For further insights into GSK stock, check out TipRanks’ Stock Analysis page.